When Does CJC-1295 Wear Off? A Practical Timing Guide

CJC-1295 at a glance:

• Drug class: Long-acting GHRH analog (research peptide)
• Route: subcutaneous injection (research use)
• Typical frequency: varies; once weekly (DAC) or daily (no-DAC) in user protocols
• Half-life: approximately 6-8 days (DAC version); ~30 minutes (no-DAC version)

If you're looking up CJC-1295 half-life, you probably have a specific question: when can I switch, how long until it clears, what happens if I miss a dose. We answer all three below.

Half-Life Defined

The half-life is the time it takes for the concentration of a drug in the bloodstream to fall by half. It governs how often a drug needs to be dosed to maintain therapeutic levels and how long the drug persists after the last dose.

For CJC-1295, the half-life is approximately 6-8 days (DAC version); ~30 minutes (no-DAC version). That number explains the varies; once weekly (DAC) or daily (no-DAC) in user protocols dosing schedule.

Time to Steady State

After starting (or changing) a dose, drug levels reach a new "steady state" after about 5 half-lives.

For CJC-1295: practical steady state takes ~5x the half-life listed above. That's why dose changes don't show their full effect immediately.

How Long CJC-1295 Stays in Your System

A common question: "if I stop CJC-1295, how long does it stay in my body?"

The standard rule of thumb is that a drug is essentially cleared after 5 half-lives. For CJC-1295: that's approximately 40 days. Effects on appetite, glucose, or other targets persist for a similar period before fully resolving.

For this compound, downstream effects depend on the cellular pathways involved.

Practical Implications

A long half-life:

• Allows less frequent dosing (better adherence)
• Smooths out peaks and troughs (often better tolerability)
• Means dose changes take longer to fully express
• Creates a longer "runway" if a dose is missed

A short half-life:

• Requires more frequent dosing
• Produces sharper concentration peaks (and matching side effects)
• Allows faster dose adjustments
• Provides faster clearance if stopped

CJC-1295, with its long half-life, falls on the long end of this spectrum.

Half-Life and Missed Doses

If a dose is missed:

• Take the missed dose as soon as you remember if you're well within the dosing interval
• Skip it if you're closer to the next dose
• Never double up

The longer the half-life, the more forgiving the missed-dose window. For CJC-1295, the missed-dose window is relatively forgiving.

Half-Life Across the Drug Class

Within the broader class of long-acting ghrh analog (research peptide), half-lives vary significantly. Half-life variation across the class affects dosing frequency and tolerability profiles. See our comparison pages for direct comparisons.

Bottom Line

If you only remember one thing about CJC-1295 pharmacokinetics, make it the half-life. Almost every other practical question traces back to it.

Frequently Asked Questions

Related Reading

• CJC-1295 101: A Plain-English Guide for 2026
• CJC-1295 Side Effects: The Complete List and How to Handle Them
• Does CJC-1295 Really Work? An Evidence-Based Results Review
• The Real CJC-1295 Price Tag in 2026 — With and Without Insurance
• The Honest Guide to MK-677: What Patients and Doctors Actually Say
• Is MK-677 Safe? An Honest Look at the Side-Effect Profile

Sources

• Stanley TL et al. Effects of Tesamorelin on Visceral Fat in HIV-Infected Patients With Lipodystrophy. NEJM 2010;363:2425.
• Nass R et al. Effects of an Oral Ghrelin Mimetic on Body Composition in Healthy Older Adults. Annals of Internal Medicine 2008;149:601.
• Teichman SL et al. Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295. JCEM 2006;91:799.

This page is informational only and is not medical advice.